147 results
8-K
zldj 4n99hk6z
31 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
EX-10.3
idmd2xy7cf9c 9ei7afy
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
wfb9oe h5xx
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.2
th0 ni3zs426s5
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
32en7oa7
30 May 23
Business combination disclosure
4:21pm
8-K
i2x r20ljx8afpgb8aus
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
he2fh 4fv33snkb
22 May 23
Business combination disclosure
7:01am
8-K
f5egdmwu9nqb
22 May 23
Other Events
6:59am